David P. Schenkein - Jun 21, 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Director
Signature
/s/ William Cook, as Attorney-in-fact for David Schenkein
Stock symbol
AGIO
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/23/2023, 04:34 PM
Previous filing
Jun 16, 2023
Next filing
Sep 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +4.98K +4.22% $0.00 123K Jun 21, 2023 Direct
holding AGIO Common stock 271K Jun 21, 2023 See footnote F1
holding AGIO Common stock 79.1K Jun 21, 2023 See footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Restricted stock unit Options Exercise $0 -4.98K -100% $0.00* 0 Jun 21, 2023 Common stock 4.98K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.
F2 Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.
F3 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F4 The restricted stock units were granted on June 21, 2022. The shares underlying the stock units will vest in full on June 21, 2023. Vested shares will be delivered to the reporting person within three business days after such shares become vested.